MEDANTA

Global Health Ltd.

NSE: MEDANTA

BSE: 543654

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Hospital

1,409.70+1.5 (+0.11%)

21 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

88.4 / 100

Value Score

13.3 / 100

Price Momentum Score

80.7 / 100

QVM Score

70.2 / 100

Key Metrics

Market Cap

37874.30

P/E (TTM)

68.10

P/B

9.56

P/S (TTM)

8.09

EV/EBITDA

38.72

CAPE (5Y)

87.07

ROE (TTM)

15.15

ROCE (TTM)

15.01

ROA (TTM)

10.43

Avg 3Y ROE

16.13

Earnings 3Y CAGR

13.84

Sales 3Y CAGR

18.01

Sales 5Y CAGR

24.97

Debt/Equity

0.30

Consensus TP

1586.00

Strong Buy %

46.67

Promoter Holding

33.00

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Global Health Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 80.7 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

80.7 / 100

Analysts have been raising forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has increased by 4.02% in the last 3 months, indicating earnings momentum

What is Earnings upgrade (3M)?

High and stable ROE

The company reported strong ROE of 15.15% for 12-month ended 30 Jun 2026 and ROE declined marginally by -15 bps from 1 year ago

What is ROE (FY)?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 21.27% for 12-month ended 30 Jun 2026 and the growth was 3.19 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 18.08

Value 21.27

-26.8103.8

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.3 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.09 in the last 1 year

What is Debt to Equity?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 68.1 indicates that the stock is expensive on a standalone basis and is at a 33.66% premium to industry median P/E

What is P/E Ratio?

Median: 50.95

Value 68.1

14.291609.64

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of 4.01% for 12-month ended 30 Jun 2026 and the growth was 8.12 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.04%

What is Dividend yield?

Neutral

High operating margin but declining trend

The company reported strong operating margin of 15.64% for 12-month ended 30 Jun 2026 but operating margin declined by -301 bps from 1 year ago

What is Operating profit margin?

Company's earnings are of moderate quality

Earnings quality score of 56.1 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

56.1 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Global Health Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Global Health Ltd. Shareholding Pattern

Quarterly breakdown of Global Health Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2014	Sep 2015	Nov 2016	Sep 2017	Aug 2018	Mar 2019	Mar 2020	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	85.79	55.45	55.45	55.45	49.27	48.63	48.42	33.08	33.08	33.07	33.06	33.05	33.04	33.04	33.04	33.03	33.03	33.01	33.01	33.01	33.01	33.00
Indian Promoter	58.98	55.45	55.45	55.45	49.27	48.63	48.42	33.08	33.08	33.07	33.06	33.05	33.04	33.04	33.04	33.03	33.03	33.01	33.01	33.01	33.01	33.00
Foreign Promoter	26.81	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.90	22.24	21.38	21.62	22.51	22.34	23.51	23.31	22.98	23.69	23.74	24.38	24.53	24.91	26.35
Mutual Funds / UTI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.84	9.52	7.99	8.24	8.63	8.27	9.03	9.59	9.00	10.36	10.66	11.83	13.12	13.91	16.03
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.12	1.13	1.03	0.99	1.05	1.03	0.60	0.59	0.66	0.69	0.66	0.63	0.61	0.62	0.66
Govt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.36	9.89	10.58	10.69	11.36	12.10	12.94	12.21	12.48	11.76	11.54	11.41	10.54	10.15	9.46
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.59	1.69	1.77	1.70	1.47	0.95	0.94	0.93	0.85	0.88	0.88	0.51	0.26	0.23	0.20
Non-Institution	14.21	44.55	44.55	44.55	50.73	51.37	51.58	45.02	44.68	45.55	45.33	44.44	44.61	43.44	43.65	43.98	43.28	43.25	42.61	42.46	42.08	40.65
Bodies Corporate	0.00	0.00	0.00	0.00	50.73	0.00	4.05	6.17	6.21	6.57	6.51	6.47	7.53	7.33	7.28	7.41	7.32	7.31	7.29	7.23	7.27	7.25
Others (incl. Retail) No. of shareholders	14.21 1	44.55 2	44.55 2	44.55 2	0.00 0	51.37 0	47.53 0	38.85 1,21,081	38.47 1,06,779	38.98 1,09,261	38.82 1,16,093	37.97 1,24,183	37.08 1,65,495	36.11 1,54,616	36.37 1,49,005	36.57 1,47,559	35.96 1,53,525	35.94 1,55,270	35.32 1,54,633	35.23 1,50,406	34.81 1,46,656	33.40 1,39,842

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Hospital	8.1%	5 / 18
2	Nifty Midcap 150	0.29%	121 / 149
3	NIFTY Large Midcap 250	0.14%	206 / 250
4	Nifty 500	0.06%	259 / 499
5	Nifty Total Market	0.06%	276 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Global Health Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Hdfc Mutual Fund	25 Jun 2026	buy	₹ 1,300.00	10.00 lac	-
Sunil Sachdeva	25 Jun 2026	sell	₹ 1,300.00	10.00 lac	-
HDFC MUTUAL FUND	25 May 2026	buy	₹ 1,225.00	10.00 lac	₹ 122.50 cr
SUNIL SACHDEVA	25 May 2026	sell	₹ 1,225.00	10.00 lac	₹ 122.50 cr
Jupiter South Asia Investment Company Limited	18 Jan 2024	sell	₹ 1,030.05	2.98 lac	₹ 30.67 cr
The Jupiter Global Fund-Jupiter India Select	18 Jan 2024	buy	₹ 1,030.05	2.98 lac	₹ 30.67 cr

Corporate Actions

History of Global Health Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.50/share
Record date: 14th Aug 2026Ex-date: 14th Aug 2026
Announced on: 14th May 2026
Dividend₹ 0.50/share
Record date: 22nd Aug 2025Ex-date: 22nd Aug 2025
Announced on: 15th May 2025

Company Profile

Overview of Global Health Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provid...

Key personnel

Mr. Yogesh Kumar Gupta

Chief Financial Officer

Mr. Rahul Ranjan

Compliance Officer, Company Secretary

Mr. Malik Mohd Ashhab

Head - Diagnostic Services

Mr. Mahi Tandon

Hospital Director - Medanta Noida Unit

Mr. Surender Kumar Sharma

Director - Projects

Mr. Brajesh Singh

Director - Projects

Mr. Mahi Tandon

Hospital Director - Medanta Noida Unit

Dr. Naresh TrehanD

Executive Chairman, Managing Director

View all

Incorporated on

13 Aug 2004

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

10,617

IPO date

16 Nov 2022

Free Float

9,02,97,056

Website

https://www.medanta.org/

Phone no.

+911244834060

Address

Medanta-The Medicity, Sector-38, GURGAON, 122001, India

Frequently Asked Questions

What is the current share price of Global Health Ltd.?

The current share price of Global Health Ltd. is ₹ 1,409.70 as of 21 Aug 2026.

What is the market capitalisation of Global Health Ltd.?

The market capitalisation of Global Health Ltd. stands at ₹ 37,874.30 Cr.

What is the PE ratio of Global Health Ltd.?

The Price-to-Earnings (PE) ratio of Global Health Ltd. is 68.10 as of the latest trailing twelve months data.

What is the ROE and ROCE of Global Health Ltd.?

Global Health Ltd. has a Return on Equity (ROE) of 15.15% and a Return on Capital Employed (ROCE) of 15.01% as per the latest financial reports.

What is the 52-week high and low of Global Health Ltd.?

The 52-week high of Global Health Ltd. is - and the 52-week low is -.

What is the dividend yield of Global Health Ltd.?

The dividend yield of Global Health Ltd. is 0.04% based on the current market price.

What is the FII and DII holding in Global Health Ltd.?

Foreign Institutional Investors (FII) hold 9.46%, Domestic Institutional Investors (DII) hold 16.69% and retail/public investors hold 33.40% of Global Health Ltd. shares.

What sector does Global Health Ltd. belong to?

Global Health Ltd. operates in the Healthcare sector. 86.67% of analysts have a Buy or Strong Buy rating on Global Health Ltd. with a consensus target price of ₹ 1,586.00, implying 12.51% upside from current levels.

What is the beta of Global Health Ltd.?

The beta of Global Health Ltd. is 0.76, indicating its price volatility relative to the broader market. Over the past 1 year, Global Health Ltd. has delivered an absolute return of 3.99%.

What is the RSI of Global Health Ltd.?

The 14-day Relative Strength Index (RSI) of Global Health Ltd. is 51.99, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Global Health Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Global Health Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Corporate Actions

Company Profile